Direct Purchasers of the diabetes drug Glumetza won preliminary approval from a federal judge in San Francisco, resolving claims that Bausch Health Cos., Lupin Ltd., and Assertio Therapeutics Inc. delayed the rollout of generic versions.
FPS is proudly powered by the legendary business software suite ZOHO ONE.
Disclaimer: Financial Power Services, LLC (FPS) is not class counsel or claims administrator. Financial Power Services, LLC does not charge any up-front fees to investigate, collect, and submit documentation concerning client refund claims. You are informed of your right to file any class action settlement claim on your own behalf without need of a third-party service. For additional case information on any particular settlement, please visit the court-approved websites, or you may contact class counsel or the claims administrator.